Literature DB >> 30191047

Fibroblast growth factor 19, a double-edged sword.

Peter Lm Jansen1.   

Abstract

Entities:  

Year:  2017        PMID： 30191047      PMCID： PMC6095402          DOI： 10.2217/hep-2017-0008

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  17 in total

1.  The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.

Authors:  Serge J L B Zweers; Klaske A C Booij; Mina Komuta; Tania Roskams; Dirk J Gouma; Peter L M Jansen; Frank G Schaap
Journal:  Hepatology       Date:  2011-12-19       Impact factor: 17.425

2.  Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.

Authors:  Chiara Degirolamo; Salvatore Modica; Michele Vacca; Giuseppe Di Tullio; Annalisa Morgano; Andria D'Orazio; Kristina Kannisto; Paolo Parini; Antonio Moschetta
Journal:  Hepatology       Date:  2014-10-30       Impact factor: 17.425

3.  Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys.

Authors:  Rama Pai; Dorothy French; Ning Ma; Kathy Hotzel; Emile Plise; Laurent Salphati; Kenneth D R Setchell; Joseph Ware; Veronique Lauriault; Leah Schutt; Dylan Hartley; Donna Dambach
Journal:  Toxicol Sci       Date:  2012-01-19       Impact factor: 4.849

Review 4.  The ascending pathophysiology of cholestatic liver disease.

Authors:  Peter L M Jansen; Ahmed Ghallab; Nachiket Vartak; Raymond Reif; Frank G Schaap; Jochen Hampe; Jan G Hengstler
Journal:  Hepatology       Date:  2017-02       Impact factor: 17.425

5.  Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.

Authors:  Insook Kim; Keiichirou Morimura; Yatrik Shah; Qian Yang; Jerrold M Ward; Frank J Gonzalez
Journal:  Carcinogenesis       Date:  2006-12-20       Impact factor: 4.944

6.  Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.

Authors:  Sung-Min Ahn; Se Jin Jang; Ju Hyun Shim; Deokhoon Kim; Seung-Mo Hong; Chang Ohk Sung; Daehyun Baek; Farhan Haq; Adnan Ahmad Ansari; Sun Young Lee; Sung-Min Chun; Seongmin Choi; Hyun-Jeung Choi; Jongkyu Kim; Sukjun Kim; Shin Hwang; Young-Joo Lee; Jong-Eun Lee; Wang-Rim Jung; Hye Yoon Jang; Eunho Yang; Wing-Kin Sung; Nikki P Lee; Mao Mao; Charles Lee; Jessica Zucman-Rossi; Eunsil Yu; Han Chu Lee; Gu Kong
Journal:  Hepatology       Date:  2014-09-22       Impact factor: 17.425

Review 7.  Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.

Authors:  Jessica Zucman-Rossi; Augusto Villanueva; Jean-Charles Nault; Josep M Llovet
Journal:  Gastroenterology       Date:  2015-06-20       Impact factor: 22.682

8.  First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.

Authors:  Margit Hagel; Chandra Miduturu; Michael Sheets; Nooreen Rubin; Weifan Weng; Nicolas Stransky; Neil Bifulco; Joseph L Kim; Brian Hodous; Natasja Brooijmans; Adam Shutes; Christopher Winter; Christoph Lengauer; Nancy E Kohl; Timothy Guzi
Journal:  Cancer Discov       Date:  2015-03-16       Impact factor: 39.397

9.  A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.

Authors:  Katrina Nicholes; Susan Guillet; Elizabeth Tomlinson; Kenneth Hillan; Barbara Wright; Gretchen D Frantz; Thinh A Pham; Lisa Dillard-Telm; Siao Ping Tsai; Jean-Philippe Stephan; Jeremy Stinson; Timothy Stewart; Dorothy M French
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

10.  Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19.

Authors:  Mei Zhou; Xueyan Wang; Van Phung; Darrin A Lindhout; Kalyani Mondal; Jer-Yuan Hsu; Hong Yang; Mark Humphrey; Xunshan Ding; Taruna Arora; R Marc Learned; Alex M DePaoli; Hui Tian; Lei Ling
Journal:  Cancer Res       Date:  2014-04-11       Impact factor: 12.701
View more
  1 in total

1.  Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer.

Authors:  Sarah S Jackson; Vanessa Van De Wyngard; Ruth M Pfeiffer; Paz Cook; Allan Hildesheim; Ligia A Pinto; Sharon H Jackson; Kelvin Choi; Ricardo A Verdugo; Mara Cuevas; Cristian Yáñez; Eduardo Tobar-Calfucoy; Rocío Retamales-Ortega; Juan Carlos Araya; Catterina Ferreccio; Jill Koshiol
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.